ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

SBI Life Insurance Company Regulatory Approval

SBI Life Insurance Company appointed Mr. Ramesh Venkateshamurthy as Deputy Chief Executive Officer effective May 29, 2026. This leadership change strengthens the company's senior management team.

Source

BSE filing, NSE: SBILIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

SBI Life Insurance Company Ltd: key numbers

Share price
₹1,767.00
Market cap
₹1,77,302 Cr
Revenue (annual)
₹1,12,315 Cr
Net profit (annual)
₹2,470 Cr
P/E (TTM)
66.8×Sector 20.8×
Promoter holding
55.31%-0.01% QoQ
FII holding
20.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from SBI Life Insurance Company Ltd

All →

Other regulatory approval announcements

All →
17:13 IST NSE
Regulatory ApprovalSandur Manganese & Iron Ores Ltd SANDUMA

Sandur Manganese & Iron Ores Regulatory Approval

Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.

iron ore RoM capacity
9.42 MTPA
10:45 IST BSE
Regulatory ApprovalNeogen Chemicals Ltd NEOGEN

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

18:38 IST NSE
Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAP

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

09:47 IST BSE
Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDY

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

21:56 IST BSE
Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTD

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

17:56 IST NSE
Regulatory ApprovalEmmbi Industries Ltd EMMBI

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.